Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Observation of unconventional edge states in 'photonic graphene'.
Plotnik Y, Rechtsman MC, Song D, Heinrich M, Zeuner JM, Nolte S, Lumer Y, Malkova N, Xu J, Szameit A, Chen Z, Segev M. Plotnik Y, et al. Among authors: malkova n. Nat Mater. 2014 Jan;13(1):57-62. doi: 10.1038/nmat3783. Epub 2013 Nov 10. Nat Mater. 2014. PMID: 24193661
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].
Boyko AN, Alifirova VM, Lukashevich IG, Goncharova ZA, Greshnova IV, Zaslavsky LG, Kotov SV, Malkova NA, Mishin GN, Parshina EV, Poverennova IY, Prakhova LN, Sivertseva SA, Smagina IV, Totolyan NA, Trinitatsky YV, Trushnikova TN, Khabirov FA, Chefranova JY, Shchur SG, Dudin VA, Pokhabov DV, Artemeva AV, Eremeeva AV, Linkova YN, Zinkina-Orikhan AV. Boyko AN, et al. Among authors: malkova na. Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(4):86-96. doi: 10.17116/jnevro202412404186. Zh Nevrol Psikhiatr Im S S Korsakova. 2024. PMID: 38676683 Clinical Trial. Russian.
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies.
Patel E, Malkova NV, Crowe D, Pederzoli-Ribeil M, Fantini D, Fanny M, Madala HR, Jenkins KA, Yerov O, Greene J, Guzman W, O'Toole C, Taylor J, O'Donnell RK, Johnson P, Lanter BB, Ames B, Chen J, Vu S, Wu HJ, Cantin S, McLaughlin M, Hsiao YS, Tomar DS, Rozenfeld R, Thiruneelakantapillai L, O'Hagan RC, Nicholson B, O'Neil J, Bialucha CU. Patel E, et al. Among authors: malkova nv. Mol Cancer Ther. 2024 Apr 2;23(4):421-435. doi: 10.1158/1535-7163.MCT-23-0336. Mol Cancer Ther. 2024. PMID: 38030380 Free PMC article.
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].
Boyko AN, Alifirova VM, Lukashevich IG, Goncharova ZA, Greshnova IV, Zaslavsky LG, Kotov SV, Malkova NA, Mishin GN, Parshina EV, Poverennova IY, Prakhova LN, Sivertseva SA, Smagina IV, Totolyan NA, Trinitatsky YV, Trushnikova TN, Khabirov FA, Chefranova JY, Shchur SG, Dudin VA, Pokhabov DV, Bolsun DD, Eremeeva AV, Linkova YN, Zinkina-Orikhan AV. Boyko AN, et al. Among authors: malkova na. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(7. Vyp. 2):43-52. doi: 10.17116/jnevro202312307243. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37560833 Clinical Trial. Russian.
[POEMS-syndrome].
Arkhipov IE, Vergunova IY, Malkova NA, Korobko DS. Arkhipov IE, et al. Among authors: malkova na. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(7. Vyp. 2):15-21. doi: 10.17116/jnevro202312307215. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37560829 Russian.
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].
Boyko AN, Alifirova VM, Lukashevich IG, Goncharova ZA, Greshnova IV, Zaslavsky LG, Kotov SV, Malkova NA, Mishin GN, Parshina EV, Poverennova IY, Prakhova LN, Sivertseva SA, Smagina IV, Totolyan NA, Trinitatsky YV, Trushnikova TN, Khabirov FA, Shchur SG, Artemyeva AV, Bolsun DD, Zinkina-Orikhan AV, Linkova YN. Boyko AN, et al. Among authors: malkova na. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(4):37-47. doi: 10.17116/jnevro202312304137. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37084363 Clinical Trial. Russian.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
5-Alkoxy-1-aryl-3-polyfluoroalkylpyrazoles with Antinociceptive Activity: Partial Agonists of TRPV1 Ion Channels.
Khudina OG, Burgart YV, Malkova NA, Shchegolkov EV, Krasnykh OP, Triandafilova GA, Malysheva KO, Solodnikov SY, Dubodel ES, Korolkova YV, Kozlov SA, Borisevich SS, Mozhaitsev ES, Saloutin VI. Khudina OG, et al. Among authors: malkova na. ChemMedChem. 2023 Jun 15;18(12):e202300063. doi: 10.1002/cmdc.202300063. Epub 2023 Apr 17. ChemMedChem. 2023. PMID: 37006199
123 results